Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2026-01-01 @ 12:36 PM
Study NCT ID:
NCT03922204
Status:
COMPLETED
Last Update Posted:
2024-12-11
First Post:
2019-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies
Sponsor:
Merus N.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-07
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-15
First Submit QC Date:
None
Study First Post Date:
2019-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-06
Last Update Post Date:
2024-12-11
Last Update Post Date Type:
ACTUAL